The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/23/8/1986/13788551/mds021.pdf
Reference26 articles.
1. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference;Roila;Ann Oncol,2010
2. Antiemetics: american Society of Clinical Oncology clinical practice guideline update;Basch;J Clin Oncol,2011
3. Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study;Fabi;Support Care Cancer,2003
4. Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines;Mertens;J Clin Oncol,2003
Cited by 241 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy‐induced nausea and vomiting management: Experiences at an academic medical center;Pediatric Blood & Cancer;2024-01-27
2. Explore Chemotherapy-Induced Nausea and Vomiting Prophylaxis Patterns and Patient-Reported Events to Suggest Improvements in Patient Care in Oncology-Specialized Hospitals in Vietnam;Research in Clinical Pharmacy;2023-12-31
3. A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I-;Investigational New Drugs;2023-12-06
4. Traditionelle Chinesische Medizin in der Onkologie: wissenschaftliche Evidenz und Leitlinien;Zeitschrift für Komplementärmedizin;2023-12
5. Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: A randomized placebo‐controlled study;Thoracic Cancer;2023-11-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3